MCF-7 represents “luminal” type breast cancer cells that express estrogen receptor (ER) and progesterone receptor (PR), whereas MDA-MB-231 is “basal” type and triple-negative (ER-, PR-, and HER2-negative) breast cancer cell line. Here, ERBB2 is linked to breast carcinoma.